Skip to main content

What happens when you stop Evenity?

Medically reviewed by Kristianne Hannemann, PharmD. Last updated on March 7, 2025.

Official answer

by Drugs.com

Within months of stopping Evenity (romosozumab), the effects on bone formation and resorption start to decline.

  • If stopped after three months, Evenity remains in the body for about two months.
  • It can take up to 12 months for P1NP (a bone formation marker) and CTX (a bone resorption marker) to return to pre-treatment levels.

Do not stop Evenity without consulting your doctor, as discontinuation may increase fracture risk.

What is Evenity used for?

Evenity is an injectable medication used to treat osteoporosis in postmenopausal women at high risk for fractures. It is prescribed for women who:

  • Have a history of osteoporosis-related fractures
  • Have multiple risk factors for fractures

Evenity is only approved for up to 12 months of use.

How does Evenity work?

Evenity is a sclerostin inhibitor, meaning it promotes bone formation and reduces bone loss by blocking sclerostin, a protein that inhibits bone growth. Studies show that it:

  • Increases the bone formation marker called procollagen type 1 N-telopeptide (P1NP), and
  • Decreases the bone resorption marker type 1 collagen C-telopeptide (CTX)

Related questions

What Is the Half-Life of Evenity?

After three doses (3 mg/kg per month for three months), Evenity has a half-life of 12.8 days. This means it takes 12.8 days for the body to eliminate 50% of the drug's maximum concentration.

Should You Stop Taking Evenity?

Talk to your healthcare provider if you need to stop taking Evenity. They can recommend other treatment options to keep your bones healthy and prevent fractures.

This is not all the information you need to know about Evenity for safe and effective use and does not take the place of your doctor’s directions. Review the full product information and discuss this information and any questions you have with your doctor or other health care provider.

References

Evenity [package insert]. Updated April 2024. Amgen Inc. Accessed July 22, 2024 at https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=471baba2-7154-4488-9891-0db2f46791e7

Krupa, K. N., et. al. Updated January 2023. Romosozumab. In: StatPearls [Internet]. Accessed July 22, 2024 at https://www.ncbi.nlm.nih.gov/books/NBK585139/

MedlinePlus [Internet]. Bethesda (MD): National Library of Medicine (US); [Updated June 2009]. SOST gene. Accessed July 22, 2024 at https://medlineplus.gov/genetics/gene/sost/

Read next

How does Evenity work?

Evenity (romosozumab-aqqg) is a humanized monoclonal antibody that works by inhibiting the activity of sclerostin, which is a small protein found in osteocytes. It increases bone formation and reduces bone loss. Continue reading

How does teriparatide (Forteo) work?

Teriparatide (Forteo), is a synthetic form of parathyroid hormone - a hormone produced naturally by the body which helps maintain blood levels of calcium within a very tight range; which in turn controls calcium levels within bone - determining how strong and dense the bones are. Continue reading

What's the difference between Prolia and Reclast?

Prolia (denosumab) and Reclast (zoledronic acid) are injections that can be used to treat or prevent osteoporosis. But they each work differently because Prolia is a monoclonal antibody (it may also be called a miscellaneous bone resorption agent) and Reclast is a bisphosphonate which means they have different side effects, other uses, tolerability, and effectiveness profiles. Both are prescription medicines. One of the main problems with Prolia is safely stopping it. Continue reading

Related medical questions

Drug information

Related support groups